To hear about similar clinical trials, please enter your email below
Trial Title:
PG Versus TG for Advanced PGC
NCT ID:
NCT06614439
Condition:
Gastric Adenocarcinoma
Gastrectomy
Conditions: Official terms:
Adenocarcinoma
Study type:
Interventional
Study phase:
N/A
Overall status:
Active, not recruiting
Study design:
Allocation:
Non-Randomized
Intervention model:
Factorial Assignment
Primary purpose:
Treatment
Masking:
None (Open Label)
Intervention:
Intervention type:
Procedure
Intervention name:
proximal gastrectomy
Description:
proximal gastrectomy
Arm group label:
Proximal gastrectomy
Intervention type:
Procedure
Intervention name:
total gastrectomy
Description:
total gastrectomy
Arm group label:
Total gastrectomy
Summary:
We conducted a retrospective study on patients with pathological stage II-III PGC who
underwent PG or TG from 2013 to 2023. Propensity score-matching was applied to adjust for
tumor size and stage between the PG and TG groups at a 1:1 ratio. We evaluated the
procedural safety, oncological, and functional outcomes.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Proximal gastric adenocarcinoma after total or proximal gastrectomy.
Exclusion Criteria:
- Non-curative resections
- Non-adenocarcinoma histology
- Distally located tumors or middle/proximally located tumors for which distal margin
could not be secured by PG
- Remnant gastric cancer
- Clinically T1N0 tumors smaller than 3 cm for which PG was clearly indicated
Gender:
All
Minimum age:
20 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
National Taiwan University Hospital Hsin-Chu Branch
Address:
City:
Hsin-Chu County
Zip:
302
Country:
Taiwan
Start date:
September 4, 2024
Completion date:
October 1, 2024
Lead sponsor:
Agency:
National Taiwan University Hospital
Agency class:
Other
Source:
National Taiwan University Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06614439
